Clinical Trials Directory

Trials / Completed

CompletedNCT03109561

Apolipoprotein E (ApoE) and Metabolism

APOE, Metabolism and Cognitive Function: An Assessment Via Indirect Calorimetry

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Lance Johnson · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

Impaired metabolism and the gene apolipoprotein E (ApoE) are independent risk factors for cognitive impairment and dementia. In humans, there are three major versions of apoE (E): E2, E3, and E4. Some studies suggest that the different versions of apoE have varying effects on whole body and brain metabolism. The goal of this project is to better understand the relationship between apoE and metabolism. This will help investigators identify new targets for the prevention and treatment of cognitive decline and dementia.

Detailed description

The investigator hopes determine whether a participant's version of ApoE affects their metabolic rate at rest and during a cognitive challenge. To determine this, the investigator will measure basal (resting) metabolic rates using a technique called indirect calorimetry (IC). This is accomplished by wearing a loose-fitting face mask that measures oxygen intake and carbon dioxide output. To more accurately measure the amount of carbohydrates, fats and proteins that the body is metabolizing, participants will be asked to provide two urine samples (one at the beginning, and one at the end, of the study). To determine what version of ApoE the participant inherited, the investigator will conduct a genetic test on DNA isolated from the participant's blood.

Conditions

Interventions

TypeNameDescription
OTHERResting State Indirect CalorimetryThe investigator will measure the amount of oxygen participants breathe in and the amount of carbon dioxide they breathe out using a portable unit. Participants will be asked wearing a loose-fitting face mask that measures oxygen intake and carbon dioxide output.
GENETICApoEThe investigator will conduct a genetic test on DNA isolated from from the participants blood. Participants will be asked to provide about 2 tablespoons.
DIAGNOSTIC_TESTMetabolismTo more accurately measure the amount of carbohydrates, fats and proteins that the participants bodies metabolize, participants will be asked to provide two urine samples (one at the beginning, and one at the end, of the study). The total amount of urine to be collected is approximately 4 teaspoons.
OTHERCognitive ChallengeParticipants will be asked to follow simple instructions that are displayed on computer screen.

Timeline

Start date
2018-04-24
Primary completion
2020-01-30
Completion
2020-01-30
First posted
2017-04-12
Last updated
2020-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03109561. Inclusion in this directory is not an endorsement.